Original Article
Pancreatic Cancer Survival Outcomes at a Tertiary Medical Center Based on Sex and Geographic Location
Abstract
Objectives: To describe the survival outcomes of patients with histologically proven primary pancreatic cancer based on geographic location and sex.Methods: We conducted a retrospective review of medical records from 2009 through 2013 of patients with pancreatic cancer using International Classification of Diseases, Ninth Revision code 157.9 and International Statistical Classification of Diseases, 10th Revision code C 25.9. The variables extracted included demographics, date of diagnosis, mode of diagnosis, duration, treatment methods, family history, history of chronic pancreatitis, and diabetes mellitus. ZIP codes were used to identify the geographic location of each subject, and rural urban commuting area codes were used to further classify the areas as metropolitan, micropolitan, small town, and rural. Population sizes were classified as metropolitan >50,000, micropolitan 10,000 to 49,999, small town 2500 to 9999, and rural <2500. Descriptive analysis and Kaplan-Meier survival for survival outcomes were performed with statistical significance identified as P < 0.05.
Results: A total of 400 medical charts were extracted for review, 301 of which belonged to patients with primary pancreatic cancer. Of the 301 cases, we identified 175 men (58%), 125 women (41%), and 1 missing sex data. There were 280 whites (95%), 8 African Americans (2%), 2 Asian Americans (0.64%), 1 Hispanic American (0.34%) and 1 Native American (0.34%), with a mean age of 63.2 ± 12.6 years. Based on geography, there were 34%, 27%, 20%, and 19% in rural areas, metropolitans, small towns, and micropolitans, respectively. No statistically significant difference was noted in sex on survival outcomes ( P = 0.85) or geography ( P = 0.62). Additional analysis revealed no statistical significant difference between sexes when stratifying by location ( P = 0.96).
Conclusions: There is no difference in survival outcomes of patients with primary pancreatic cancer based on sex or geographic location. Our survival outcomes differ from the national survival outcomes, which reveal that mortality in men is higher than it is in women.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Surveillance Epidemiology and End Results. US cancer statistics: 1993-2013 incidence and mortality report. https://nccd.cdc.gov/uscs. Accessed August 29, 2016.
3. Boyle P, Hsieh CC, Maisonneuve P, et al. Epidemiology of pancreas cancer (1988). Int J Pancreatol 1989;5:327-346.
4. Hassan MM, Bondy ML, Wolff RA, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007;102:2696-2707.
5. American Lung Association. Women and tobacco use. http://www.lung.org/stop-smoking/smoking-facts/women-and-tobacco-use.html. Accessed August 18, 2016.
6. O' CB, Atoria CL, O' EM, et al. Costs and trends in pancreatic cancer treatment. Cancer 2012;118:5132-5139.
7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
8. Zhang J, Dhakal I, Ning B, et al. Patterns and trends of pancreatic cancer mortality rates in Arkansas, 1969-2002: a comparison with the US population. Eur J Cancer Prev 2008;17:18-27.
9. SEER Stat Fact Sheets. Pancreas cancer. http://seer.cancer.gov/statfacts/html/pancreas.html. Accessed August 29, 2016.
